Biotech and Pharmaceuticals


  • 2015's strong outlook for healthcare IPOs  Thursday, 29 Jan 2015 | 5:40 AM ET

    Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.

  • The rise and rise of life sciences  Thursday, 29 Jan 2015 | 4:55 AM ET

    George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.

  • Cracking down on cat allergies  Thursday, 29 Jan 2015 | 4:30 AM ET

    Steve Harris, CEO of Circassia, says his company is combating allergies by tackling how they affect people's immune systems, rather than simply making products that provide "symptomatic relief".

  • Drugmakers get mysterious invites to White House Wednesday, 28 Jan 2015 | 5:06 PM ET
    President Barack Obama

    The heads of research at several large drugmakers have received mysterious invitations to the White House for a meeting Friday morning.

  • Amgen profit tops expectations Tuesday, 27 Jan 2015 | 5:04 PM ET
    Amgen building in South San Francisco, California.

    Amgen on Tuesday reported higher-than-expected fourth-quarter profit.

  • Bristol-Myers quarterly profit beats forecasts Tuesday, 27 Jan 2015 | 9:22 AM ET
    Bristol-Myers Squibb R&D headquarters.

    Bristol-Myers Squibb reported higher-than-expected earnings, helped by strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.

  • Pfizer's 2015 forecast disappoints, hit by dollar Tuesday, 27 Jan 2015 | 7:36 AM ET

    Pfizer reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased.

  • Impact of a strong U.S. dollar  Tuesday, 27 Jan 2015 | 5:50 AM ET

    Cole Smead, portfolio manager at Smead Capital Management, discusses the strong U.S. dollar and how it will affect sectors like pharmaceuticals.

  • Novartis flags faster sales, profit growth for 2015 Tuesday, 27 Jan 2015 | 2:48 AM ET
    Joe Jimenez, CEO of Novartis, at 2015 WEF in Davos, Switzerland.

    Novartis forecast sales and profits to grow at a faster pace this year driven by recent drug successes and its portfolio overhaul.

  • First case of H7N9 bird flu found in North America Monday, 26 Jan 2015 | 5:18 PM ET
    A technician deals with test reagents for bird flu virus

    Canadian health authorities say they have diagnosed the first case of bird flu in a British Columbia woman who recently returned from China.

  • Bird flu detected at California turkey farm Monday, 26 Jan 2015 | 12:45 PM ET

    A California turkey farm has been quarantined after confirmation of an outbreak of the highly pathogenic H5N8 avian influenza strain.

  • Scientists unboil an egg, and it may be a big deal Friday, 23 Jan 2015 | 4:13 PM ET

    The ability to unfold a protein and return it to its original state could save money in everything from cancer research to food production.

  • Ebola vaccine trials to begin in Liberia Thursday, 22 Jan 2015 | 3:45 PM ET
    Health workers wearing protective equipment are pictured at the Island Clinic in Monrovia, Liberia.

    A clinical trial of two experimental Ebola vaccines is expected to start in Liberia in the next couple of weeks, the NIH said.

  • Drug-laden drone crashes near US-Mexico border Thursday, 22 Jan 2015 | 10:57 AM ET
    In this image released by the Tijuana Municipal Police on Jan. 21, 2015, a drone loaded with methamphetamine lies on the ground after it crashed into a supermarket parking lot in the city of Tijuana on Tuesday Jan. 20, 2015.

    Police in a Mexican border city said that a drone overloaded with illicit methamphetamine crashed into a supermarket parking lot.

  • Meet San Francisco's new weed of the month club Wednesday, 21 Jan 2015 | 4:02 PM ET

    Marvina is a premium cannabis provider that offers a monthly delivery service of marijuana to consumers in San Francisco.

  • Bristol-Meyers Squibb taps a doctor as new CEO Tuesday, 20 Jan 2015 | 5:29 PM ET
    Bristol-Myers Squibb R&D headquarters.

    Pharmaceutical giant Bristol-Myers Squibb named Dr. Giovanni Caforio as its new CEO on Tuesday.

  • Vaccinating children becoming unaffordable: Report Tuesday, 20 Jan 2015 | 2:22 PM ET
    A child receives a vaccine in a makeshift field clinic of the Doctors Without Borders (MSF) organisation during a vaccination program against measles in Bangui, Central African Republic.

    The cost of a vaccination program is 68 times more expensive than is was in 2001. Doctors Without Borders wants companies to slash prices.

  • Davos: Who needs a 'wake up call'?  Tuesday, 20 Jan 2015 | 11:25 AM ET

    Discussing the current state of Europe at Davos 2015, Karl-Ludwig Kley, chairman of Merck says the lack of coordination and cohesion in European businesses is the current problem.Meanwhile political leaders need a wake-up call.

  • Supreme Court rules for Teva over drug patent Tuesday, 20 Jan 2015 | 10:48 AM ET
    An employee collects newly-manufactured pills at Teva Pharmaceutical Industries headquarters in Jerusalem, Israel.

    The U.S. Supreme Court ruled for Teva Pharmaceutical Industries in its fight with generic drug manufacturers over patent protections.

  • Benefits firms shouldn't play drug favorites: CEO Tuesday, 20 Jan 2015 | 10:00 AM ET

    Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer told CNBC on Tuesday that benefits companies should not try to practice medicine.

Contact Biotech and Pharma


    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More


  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.